Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Glioblastoma 5Recurrence 4Head and Neck Neoplasms 3Diffuse Intrinsic Pontine Glioma 3Glioma 2Brain Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Solid Tumor 1Recurrence of Head and Cancer in Irraiated Area 1Pelvic Neoplasms 1Pancreatic Neoplasms 1Nasopharyngeal Neoplasms 1Nasopharyngeal Diseases 1Nasopharyngeal Carcinoma 1Central Nervous System Neoplasms 1Carcinoma, Squamous Cell 1Brain Stem Neoplasms 1

Interventions

Temozolomide 162Radiosurgery 114Radiotherapy 99Bevacizumab 95Magnetic Resonance Spectroscopy 64Carboplatin 48Etoposide 34Surgical Procedures, Operative 33Irinotecan 33pembrolizumab 32Nivolumab 32Cyclophosphamide 32Erlotinib Hydrochloride 31Radiation 29Carmustine 28Cisplatin 25Lomustine 24Trastuzumab 23Ipilimumab 23Filgrastim 23Vincristine 20Mental Status and Dementia Tests 20Aminolevulinic Acid 19Topotecan 18Pemetrexed 18Capecitabine 18Specimen Handling 17Sorafenib 15Radiotherapy, Intensity-Modulated 15Imatinib Mesylate 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Brain Neoplasms × Re-Irradiation × Clear all
NCT06093165 2023-10-23

REMIT

Rigshospitalet, Denmark

Phase NA Not yet recruiting
59 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Brain Neoplasms, Brain Stem Neoplasms

NCT01469247 2022-10-20

Diffuse Intrinsic Pontine Glioma (DIPG) Reirradiation (ReRT)

M.D. Anderson Cancer Center

Phase 1/2 Completed
12 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Brain Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡